85 MEMORIAL ROAD, #415, WEST HARTFORD, CT
Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Investor Presentation
Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Veradermics, Inc. Closes $384.4M Public Offering of Common Stock
Preliminary Cash Position of $390.8 Million as of March 31, 2026
Financial Results, Press Release
Fifth Restated Certificate of Incorporation Filed for IPO
Q2
Q1
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Prospectus filed pursuant to Rule 424(b)(4)
Registration Statement for Securities to be Offered to Employees
Certificate
No filings found
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Free Writing Prospectus
S-1MEF